Webinar Recording: IP Trends for Emerging Penn Engineering Technologies
This webinar discusses the latest trends in intellectual property and patenting for engineers, including robotics, nanotechnology, med-tech and more
Inspiring people, place, and purpose
Gutmann spearheaded the creation of an innovation ecosystem for Penn, Philadelphia, and beyond by transforming technology transfer at Penn to be both more faculty- and industry-friendly.
Penn Startups Raising Capital – Spring 2022
PCI supports and facilitates startup formation and growth through our startup creation programs and our licensing partnerships. This list of Penn affiliated startups are actively fundraising.
Medical device startup Neuralert has big 2022 plans
The device's algorithm maps out asymmetric arm movements or weakness, a tell-tale sign of a stroke, CEO Eric Corkhill said. Here's why he's so excited about its potential.
USPTO launches new Patent Public Search tool and webpage
The USPTO announced a new Patent Public Search tool that provides more convenient, remote, and robust full-text searching of all U.S. patents and published patent applications.
Decade-long remission after CAR T cell therapy
Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.
It’s official: Philly Tech Week is back and IRL in 2022
The 12th annual celebration of technology, entrepreneurship and innovation will be held May 6 to 14, 2022 with a mix of in-person and virtual events.
Two Penn spinouts on the Technical.ly Philly RealLIST standout tech companies
Of the 20 companies on the Technical.ly Philly RealLIST, two are Penn spinout companies: Lumify and Neuralert.
ExynAI has been shortlisted as a finalist for a SXSW Innovation Award
For the 2022 category of Robotics and Hardware. The Exyn team will be going to Austin for the awards.
The Center for Breakthrough Medicines and Penn partner in the manufacturing of gene therapies
Penn’s Innovation in Process Science combines with CBM manufacturing capability to develop large-scale gene therapy manufacturing capacity, testing, and analytics